Benchling

Other Healthcare Technology Systems · San Francisco, CA · Founded 2012 · Privately Held (backing)

Developer of a lab collaboration platform designed to make life science research quick and collaborative. Benchling is based in San Francisco, CA and was founded in 2012. It was valued at $6.1 billion at its later-stage round in Oct 2021, the last priced event on record. It has raised $418 million across 2 recorded rounds; the latest was a $200 million Series E in Apr 2021.

PMV mark · valuation
$6.1B
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$417.9M
Last round
Later Stage VC (Series E)
Apr 2021
What is Benchling worth?
$6.1BPrivateMarketView mark · Oct 2026

Valued at $6.1B at its later-stage round, Oct 2021. Nothing has traded since.

Free account
More of Benchling with a free account
  • ·The complete investor list: 44 names
  • ·Watch Benchling: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Benchling funding history

2 rounds
DateRoundRaisedPost-money
Apr 2021Later Stage VC (Series E)$200.0M▮
Apr 2016Early Stage VC$7.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Benchling valuation

Benchling was valued at $6.1 billion at its later-stage round in Oct 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Benchling raised?

Benchling has raised $418 million in total; 2 of its rounds are on record. The largest on record was a $7 million early-stage round in Apr 2016; the most recent was a $200 million Series E in Apr 2021.

Benchling has filed 1 Form D with the SEC, most recently in Oct 2016 ($7 million sold to 16 investors).

Comparable companies

Comparable other healthcare technology systems names by valuation on PrivateMarketView: Carbon Health ($1.3 billion), Element Biosciences ($1 billion) and Zocdoc ($446 million).

How Benchling's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Benchling, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Benchling

What is Benchling worth?
Benchling is valued at $6.1B as of Oct 2026. Valued at $6.1B at its later-stage round, Oct 2021. Nothing has traded since.
How much has Benchling raised?
Benchling has raised $417.9M in total funding across 2 recorded rounds.
When did Benchling last raise?
Benchling last raised in Apr 2021 (Later Stage VC (Series E)), raising $200.0M.